Three Greeks in Canada’s Top 40 Under 40 for 2017
Canada’s Top 40 Under 40 is a dynamic awards program that identifies outstanding young achievers in Canadian business, visionaries and innovators changing the way things are done. They are inspiring others and already giving back to their communities and to Canada. And every one of them is under the age of forty. In the 2017 list, 3 Greeks are featured.
Founded in 1995 by Caldwell Partners, Top 40 is the country’s most coveted award for young business leaders, often the first program to shine the spotlight on many successful Canadian notables. Honourees have gone on to create remarkable track records of achievement post-award; the ranks of Top 40 alumni include hundreds of nationally and internationally prominent CEOs, CFOs, executives, and entrepreneurs.
The Greeks featured in the list are Foteini Agrafioti, Tony Lourakis and Aristotle Voineskos.
Dr. Foteini Agrafioti is founder of Architech Labs. Prior to joining Architech, Dr. Agrafioti was a founder and CTO at Nymi Inc., and is one of the inventors of the Nymi wristband and HeartID authentication technology.
Tony Lourakis is Co-Founder and CEO of Complete Innovations, one of the fastest growing North American technology companies, he has been recognized as one of Canada’s best young entrepreneurs. His company has created Fleet complete, its flagship product, capable of enabling 6,000 customers across North America to track, optimize and manage over 80,000 vehicles, assets and people. With his leadership, Complete Innovations has grown continuously and is ranked in lists as Braham300, Profit500, Fast50 among others for several years. His excellent leadership skills, along with Tony’s in depth knowledge of software design, have been instrumental to the company’s growth and current position as the market leader. Read more about Tony Lourakis.
Aristotle Voineskos is Director of the Slaight Family Centre for Youth in Transition, and is Head of the Kimel Family Translational Imaging-Genetics Laboratory in the Campbell Family Mental Health Research Institute at CAMH. He is a Canada Research Chair in Neuroimaging of Schizophrenia, and Associate Professor of Psychiatry at the University of Toronto. Dr. Voineskos’s work combines multi-modal neuroimaging and genetics approaches to map gene effects on brain circuitry with a view to discovering vulnerability pathways for severe mental illness using a lifespan approach. He also holds a special interest in leading early identification and intervention for young people with emerging mental illness.